Blue Owl Capital Corporation remains a hold, offering an attractive 11.7% dividend yield but facing declining NAV and modest earnings growth. OBDC's portfolio is well-diversified, with 98% floating ...

Large pension funds and other big institutional investors have started to borrow against their private equity portfolios to raise cash after a slowdown in dealmaking activity and public offerings has ...

I recently reviewed a curious car that topped out at 30 mph. Technically, the Wink Mark3 isn’t a “car". It’s an “LSV” or Low-Speed Vehicle - the same designation the DOT gives to golf carts. But the ...

Chethan is a reporter at Android Police, focusing on the weekend news coverage for the site. He has covered tech for over a decade with multiple publications, including the likes of Times Internet, ...

Naspers and Prosus both still trade at a NAV discount even when ignoring the VC portfolio, which may not be optimally positioned for the AI boom. At the group level, the Tencent stake which backs the ...

Disclosure: The author of this story owns shares in MicroStrategy (MSTR). Shares of self-described Bitcoin Development Company MicroStrategy (MSTR) continue to advance relative to the price of bitcoin ...

Forbes contributors publish independent expert analyses and insights. Michael writes on high income assets that help people retire early. At my CEF Insider service, a fund’s discount to net asset ...

Kelsey is a Senior Writer for Collider, responsible for lists revolving around TV and movies. A self-proclaimed TV and movie junkie who has been in the digital media space for seven years, Kelsey has ...

Google is testing another change for the Play Store’s new persistent navigation bar. It makes the bar disappear when you scroll down on the main feeds, search results, or app listings, and it ...

Navigator Medicines has equipped itself with $100 million in series A funds as the young biotech charts a course for its newly acquired autoimmune drugs. The company, which was founded earlier this ...